Non-small Cell Lung Cancer
📧 Sign up to get email alerts when something new happens for Non-small Cell Lung Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2014-12-30Clinical Trial Update: Dose Escalation of Icotinib in Advanced Non-small Cell Lung Carcinoma (NSCLC) Patients Evaluated as Stable Disease [Phase 2]
A Phase 2 dose-escalation trial evaluating icotinib in patients with advanced non-small cell lung cancer who had stable disease.
-
CLINICAL_TRIALS trial_result · 2014-12-29Clinical Trial Update: A Study of Ramucirumab (IMC-1121B) With Paclitaxel and Carboplatin in Non-small Cell Lung Cancer [Phase 2]
A Phase 2 study of ramucirumab plus paclitaxel and carboplatin in non-small cell lung cancer completed, with results posted on 2014-12-29.
-
CLINICAL_TRIALS trial_result · 2014-12-29Clinical Trial Update: A Study of Chemotherapy and Ramucirumab Versus Chemotherapy Alone in Second Line Non-Small Cell Lung Cancer (NSCLC) Participants Who Received Prior First Line Platinum-based Chemotherapy [Phase 3]
Phase 3 study comparing chemotherapy with ramucirumab versus chemotherapy alone in second-line NSCLC after platinum-based first-line therapy…
-
CLINICAL_TRIALS trial_result · 2014-12-29Clinical Trial Update: Pemetrexed and Best Supportive Care Versus Placebo and Best Supportive Care in Non-Small Cell Lung Cancer (NSCLC) [Phase 3]
Phase 3 trial evaluating pemetrexed with best supportive care versus placebo with best supportive care in non-small cell lung cancer has com…
-
CLINICAL_TRIALS trial_result · 2014-12-29Clinical Trial Update: A Study of Pemetrexed and Carboplatin/Cisplatin or Gemcitabine and Carboplatin/Cisplatin With or Without IMC-1121B in Participants Previously Untreated With Recurrent or Advanced Non-Small Cell Lung Cancer (NSCLC) [Phase 2]
Phase 2 trial update evaluating pemetrexed and platinum combinations with or without IMC-1121B in previously untreated recurrent or advanced…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2014-12-23Clinical Trial Update: Gamma-Secretase Inhibitor RO4929097 and Cediranib Maleate in Treating Patients With Advanced Solid Tumors [Phase 1]
This Phase 1 trial evaluated the combination of RO4929097, a gamma-secretase inhibitor, with Cediranib maleate in adults with advanced solid…
-
CLINICAL_TRIALS research · 2014-12-23Clinical Trial Update: Erlotinib With Concurrent Brain Radiotherapy and Secondary Brain Radiotherapy After Recurrence With Erlotinib in NSCLC Non-increased-intracranial-pressure Symptomatic Brain Metastases [Phase 2]
A Phase 2 clinical trial evaluating erlotinib with concurrent brain radiotherapy and secondary brain radiotherapy after recurrence in patien…
-
CLINICAL_TRIALS trial_result · 2014-12-19Clinical Trial Update: A Study of Tarceva (Erlotinib) in Patients With Advanced Non-Small Cell Lung Cancer Naive to Chemotherapy [Phase 2]
Phase 2 study evaluating Tarceva (erlotinib) in patients with advanced non-small cell lung cancer who have not received chemotherapy, with r…
-
CLINICAL_TRIALS trial_result · 2014-12-18Clinical Trial Update: GEfitinib Plus viNOrelbine in Advanced EGFR Mutated NSCLC. GENOA Trial [Phase 2]
Phase 2 trial evaluating gefitinib plus vinorelbine in advanced EGFR-mutated non-small cell lung cancer (GENOA trial) with status currently …
-
CLINICAL_TRIALS withdrawal · 2014-12-18Clinical Trial Update: Consolidation Chemotherapy/Concurrent Chemo-radiotherapy for Inoperable Stage III Non-small Cell Lung Cancer (NSCLC) [Phase 2]
A Phase 2 trial evaluating consolidation chemotherapy with concurrent chemoradiotherapy for inoperable Stage III non-small cell lung cancer …
-
CLINICAL_TRIALS trial_result · 2014-12-17Clinical Trial Update: Personalized Therapy in Non-small Cell Lung Cancer [Phase 2]
Phase 2 trial update for personalized therapy in non-small cell lung cancer has completed. The summary does not include detailed trial resul…
-
CLINICAL_TRIALS trial_result · 2014-12-16Clinical Trial Update: Safety and Efficacy Study of a New Chemotherapy Agent to Treat Non Small Cell Lung Cancer. [Phase 2]
A Phase 2 trial evaluating a new chemotherapy agent for non-small cell lung cancer reports safety and efficacy results.
-
CLINICAL_TRIALS trial_result · 2014-12-11Clinical Trial Update: Utility of Routine Cervical Mediastinoscopy in Clinical Stage I Non-Small Cell Lung Cancer (NSCLC)
This completed trial evaluated whether routine cervical mediastinoscopy adds value for staging patients with clinical stage I non-small cell…
-
CLINICAL_TRIALS trial_result · 2014-12-11Clinical Trial Update: Erlotinib as First-line Treatment of Advanced Non-small Cell Lung Cancer (NSCLC) for Patients Unfit for Chemotherapy [Phase 2]
A Phase 2 study evaluating erlotinib as first-line therapy for advanced non-small cell lung cancer in patients unfit for chemotherapy has be…
-
CLINICAL_TRIALS trial_result · 2014-12-09Clinical Trial Update: Phase II Randomized Study on Locally Advanced NSCLC Escalated Dose on Individual Basis Treatment With Radiochemotherapy [Phase 2]
A Phase II randomized study evaluating escalated, individualized radiochemotherapy for locally advanced non-small cell lung cancer has been …
-
CLINICAL_TRIALS trial_result · 2014-12-09Clinical Trial Update: Stereotactic Precision And Conventional Radiotherapy Evaluation [NA]
Update notes a clinical trial comparing stereotactic precision radiotherapy with conventional radiotherapy for non-small cell lung cancer, b…
-
CLINICAL_TRIALS trial_result · 2014-12-08Clinical Trial Update: Bevacizumab in Combination With Chemotherapy in Patients With Advanced or Recurrent Non-squamous NSCLC
Clinical trial update reporting completion of a study evaluating bevacizumab in combination with chemotherapy for advanced or recurrent non-…
-
CLINICAL_TRIALS trial_result · 2014-12-08Clinical Trial Update: Bortezomib, Paclitaxel, Carboplatin and Radiation Therapy for Non-Small Cell Lung Cancer [Phase 1, Phase 2]
Phase 1/2 trial evaluating the combination of bortezomib, paclitaxel, carboplatin, and radiation therapy for non-small cell lung cancer has …
-
CLINICAL_TRIALS trial_result · 2014-12-08Clinical Trial Update: Phase IV Study of Tarceva in Patients With Advanced Stage IIIB/ IV Non-small Cell Lung Cancer (NSCLC)
A Phase IV study evaluating erlotinib (Tarceva) in patients with advanced non-small cell lung cancer has completed.
-
CLINICAL_TRIALS research · 2014-12-05Clinical Trial Update: Study Of Use Of Pemetrexed In Patients With Non-Small Lung Cancer Metastatic In Andalusian Public Health System
This entry reports a clinical trial evaluating pemetrexed for metastatic non-small cell lung cancer in the Andalusian Public Health System. …
-
CLINICAL_TRIALS trial_result · 2014-12-04Clinical Trial Update: Safety and Efficacy Study of a New Chemotherapy Agent to Treat Non-small-cell Lung Cancer [Phase 2]
Phase 2 trial sponsored by Bayer evaluating a new chemotherapy agent for non-small cell lung cancer has completed and reports safety and eff…
-
CLINICAL_TRIALS trial_result · 2014-12-04Clinical Trial Update: BIBF 1120 + Docetaxel (Japan) in Patients With Advanced Non-small-cell Lung Cancer, Phase I [Phase 1]
Phase I study in Japan evaluating the combination of BIBF 1120 (nintedanib) with docetaxel in patients with advanced non-small-cell lung can…
-
CLINICAL_TRIALS trial_result · 2014-12-04Clinical Trial Update: First-Line Chemotherapy and Panitumumab in Advanced Non-Small Cell Lung Cancer [Phase 2]
A Phase 2 trial evaluating first-line chemotherapy with panitumumab in advanced non-small cell lung cancer has been terminated.
-
CLINICAL_TRIALS trial_result · 2014-12-03Clinical Trial Update: Cisplatin, Vinorelbine, and Radiation Therapy in Treating Patients With Stage III Non-Small Cell Lung Cancer That Cannot Be Removed By Surgery [Phase 3]
This document reports the completion/update of a Phase 3 trial evaluating cisplatin, vinorelbine, and radiation therapy for patients with un…
-
CLINICAL_TRIALS trial_result · 2014-12-03Clinical Trial Update: Erlotinib in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer [Phase 3]
A Clinical Trial Update describing a Phase 3 evaluation of erlotinib for stage III or stage IV non-small cell lung cancer.